Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.31% | 20.16% | 12.08% | 4.47% | 0.20% |
| Total Depreciation and Amortization | 9.10% | 5.09% | -5.16% | 25.48% | 37.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 246.98% | -88.82% | -93.44% | -96.65% | -105.61% |
| Change in Net Operating Assets | -183.26% | -168.42% | -203.59% | -989.61% | 202.19% |
| Cash from Operations | -44.36% | -38.70% | -56.68% | -29.74% | 15.32% |
| Capital Expenditure | -252.31% | -202.44% | -630.69% | 56.18% | 92.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -2,390.41% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 19.20% | -168.32% | -0.96% | 68.11% | 80.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | -72.51% | 257.04% | 471.66% | 469.99% | 469.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | 1,276.34% | 1,276.34% | 1,276.34% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 140.33% | 100.00% | 100.00% | 95.74% |
| Cash from Financing | -72.60% | 106.28% | 917.42% | 914.46% | 951.07% |
| Foreign Exchange rate Adjustments | 128.77% | -932.20% | 195.26% | 99.07% | 72.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.60% | 162.66% | 168.45% | 171.14% | 183.97% |